This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Mind of Yohei Yoshihama
Introduction: Yohei Yoshihama, a talented inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With one notable patent to his name, he exemplifies the innovative spirit found within the scientific community.
Latest Patents: Yoshihama's most recent patent focuses on a Pyrrolopyrazole derivative. The invention describes a low molecular compound that effectively inhibits phosphatidylserine synthase 1 and includes a pharmaceutically acceptable salt thereof. This pharmaceutical compound also serves as a therapeutic agent for cancer, as it suppresses the function of phosphatidylserine synthase 2. The compound is represented by a specific formula which is defined in detail within the patent specification.
Career Highlights: Yohei Yoshihama is affiliated with Daiichi Sankyo Company, Limited, where he is recognized for his innovative research and development efforts. His work primarily concentrates on creating novel compounds with potential therapeutic applications, showcasing his commitment to advancing medical science.
Collaborations: Throughout his career, Yoshihama has collaborated closely with colleagues such as Hidenori Namiki and Masanori Saitou. These partnerships have fostered an environment of creativity and collaboration, allowing for the development of groundbreaking pharmaceutical solutions.
Conclusion: Yohei Yoshihama stands as a prime example of an inventor dedicated to pushing the boundaries of science through innovation. His patent for a Pyrrolopyrazole derivative not only highlights his expertise but also contributes to the ongoing fight against cancer, illustrating how individual inventors can make a significant impact in healthcare.